Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care

Core Insights - Thermo Fisher Scientific has launched the PPD CorEvitas Alzheimer's Disease Registry to enhance real-world evidence in neurodegenerative care [1] Company Developments - The new registry aims to collect comprehensive data on Alzheimer's disease, which will support research and improve patient care [1] - This initiative reflects the company's commitment to advancing healthcare through innovative solutions and data-driven insights [1] Industry Impact - The establishment of the Alzheimer's Disease Registry is expected to contribute significantly to the understanding of neurodegenerative diseases and inform treatment strategies [1] - By focusing on real-world evidence, the registry may help bridge gaps in clinical research and patient outcomes in the neurodegenerative care sector [1]